124 related articles for article (PubMed ID: 7040726)
1. [The method of leucovorin administration in high dose methotrexate regimen (author's transl)].
Taguchi H
Rinsho Ketsueki; 1981 Nov; 22(11):1687-99. PubMed ID: 7040726
[No Abstract] [Full Text] [Related]
2. [Weekly high-dose methotrexate with citrovorum factor rescue for non-Hodgkin's lymphoma--serum methotrexate level and safety administration (author's transl)].
Sasaki K; Fujimoto T; Goya N
Rinsho Ketsueki; 1979 Jan; 20(1):90-7. PubMed ID: 311390
[No Abstract] [Full Text] [Related]
3. [Massive dose methotrexate with citrovorum factor rescue: MTX-pharmacokinetics, excretion pattern, and techniques for safety administration (author's transl)].
Sasaki K; Fujimoto T
Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):988-96. PubMed ID: 317293
[No Abstract] [Full Text] [Related]
4. Studies with high-dose methotrexate--historical background.
Goldin A
Cancer Treat Rep; 1978 Feb; 62(2):307-12. PubMed ID: 346222
[No Abstract] [Full Text] [Related]
5. [Experiences with enterally and parenterally applied leucovorin following therapy with high doses of methotrexate in malignant tumors (author's transl)].
Vahrson H; Gorges K
Med Klin; 1976 Oct; 71(41):1720-3. PubMed ID: 1086422
[TBL] [Abstract][Full Text] [Related]
6. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
[No Abstract] [Full Text] [Related]
7. Membrane transport considerations in high-dose methotrexate regimens with leucovorin rescue.
Goldman ID
Cancer Treat Rep; 1981; 65 Suppl 1():13-7. PubMed ID: 6173119
[No Abstract] [Full Text] [Related]
8. New "rescue" with massive doses of citrovorum factor for potentially lethal methotrexate toxicity.
Djerassi I; Kim JS; Nayak N; Ohanissian H; Adler S; Hsieh S
Cancer Treat Rep; 1977 Jul; 61(4):749-50. PubMed ID: 301784
[No Abstract] [Full Text] [Related]
9. Folic acid and folinic acid supplementation during low-dose methotrexate therapy for rheumatoid arthritis: comment on the article by van Ede et al.
Morgan SL; Baggott JE; Alarcón GS; Koopman WJ
Arthritis Rheum; 2002 May; 46(5):1413-4. PubMed ID: 12115259
[No Abstract] [Full Text] [Related]
10. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
[TBL] [Abstract][Full Text] [Related]
11. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
12. Folic acid and folinic acid supplements and methotrexate therapy: comment on the article by Morgan et al.
Cronstein BN
Arthritis Rheum; 2005 Apr; 52(4):1338-9; author reply 1339-40. PubMed ID: 15818677
[No Abstract] [Full Text] [Related]
13. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
14. [Effect of methotrexate-citrovorum factor (MTX-CF) rescue therapy in a case of malignant histiocytosis with disseminated intravascular coagulation (author's transl)].
Fukuhara S; Kim R; Aoki Y; Okada S; Yoneda M; Kita K; Nasu K; Tatsumi E; Shirakawa S; Uchino H
Rinsho Ketsueki; 1981 Jul; 22(7):1145-51. PubMed ID: 6977047
[No Abstract] [Full Text] [Related]
15. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
[TBL] [Abstract][Full Text] [Related]
16. [Determination of MTX plasma concentration in cancer patients following administration of HD-MTX-CFR (author's transl)].
Wang YX; Zhang QF; Zhang NF; Zhang XL; Kang SH
Yao Xue Xue Bao; 1981 Nov; 16(11):815-20. PubMed ID: 6979162
[No Abstract] [Full Text] [Related]
17. Folic acid supplementation during methotrexate therapy: it makes sense.
Morgan Sl; Alarcón GS; Krumdieck CL
J Rheumatol; 1993 Jun; 20(6):929-30. PubMed ID: 8350325
[No Abstract] [Full Text] [Related]
18. Effect of preoperative high-dose methotrexate and leucovorin rescue on incidence of wound infection in rats.
Kraft RL; Goldberg NH; Ariyan S
Surg Forum; 1979; 30():537-9. PubMed ID: 317183
[No Abstract] [Full Text] [Related]
19. Methotrexate in psoriasis with and without leucovorin: effect of different dosage schedules on acute liver toxicity.
Zachariae H; Bjerring P
Acta Derm Venereol; 1982; 62(5):446-8. PubMed ID: 6183902
[TBL] [Abstract][Full Text] [Related]
20. [Correct use of methotrexate].
Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A
Ned Tijdschr Geneeskd; 2009; 153():A696. PubMed ID: 19785852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
